Does a three week treatment with microcurrents improve the functional level of people with fibromyalgia syndrome?

Completed

• Conditions: Fibromyalgia syndrome (FMS); Nervous System Diseases; Other soft tissue disorders, not elsewhere classified

• Registration Number: ISRCTN04459421
• Lead Sponsor: niversity Rovira i Virgili (Spain)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09-09
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

1. Adult patients of either sex diagnosed with FMS in accordance with the American College of Rheumatology?s criteria (final age range at end of recruitment was 33-71 years)
2. Recruited from the Catalan Association for People Affected by FMS

Exclusion Criteria

1. Suffering from a multiple organic disease
2. Pregnant
3. Patients with a demand-type cardiac pacemaker
4. Receiving physiotherapy treatment or having finished treatment in the previous month

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fibromyalgia Impact Questionnaire (Cuestionario de Impacto de la Fibromialgia [CIF]) <br>The values of the CIF are between 0 and 100, 0 being the best state of health and 100 the worst. CIF will be assessed at the start of treatment (CIF0), at the end of the treatment (CIF1) and at one month after treatment (CIF2).

Secondary Outcome Measures

Name	Time	Method
Visual analog scale (VAS) (0 = no pain, 10 = unbearable pain), assessed at the start of treatment (VAS0), at end of the treatment (VAS1) and at one month after treatment (VAS2).